Browse Data and Analysis
Filter
Search Data and Analysis
- 17 results found
- (-) Israel
- (-) Grenada
- (-) New Technologies
- Clear all
Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology since 2023.
Israel has no policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There have been no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology since 2022.
As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.
With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...
As of October 2021, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology...
As of September 2020, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products.
As of October 2019, there are no changes in Israel’s policy towards plant and animal biotechnology compared to 2018.
Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....
As of October 2018, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.
Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....
As of June, 2017, Israel does not have a policy that restricts the use of imported genetically engineered (GE) commodities or derivative products.
Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead....